BioXcel Therapeutics (BTAI) Short Interest Ratio & Short Volume $0.36 -0.03 (-8.58%) (As of 11:34 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BioXcel Therapeutics Short Interest DataBioXcel Therapeutics (BTAI) has a short interest of 1.05 million shares. This marks a 16.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 839,026 shares to cover all short positions.Current Short Interest1,050,000 sharesPrevious Short Interest898,700 sharesChange Vs. Previous Month+16.84%Dollar Volume Sold Short$432,705.00Short Interest Ratio1.7 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares42,748,000 sharesPercentage of Shares Shorted2.46%Today's Trading Volume649,351 sharesAverage Trading Volume839,026 sharesToday's Volume Vs. Average77% Short Selling BioXcel Therapeutics? Sign up to receive the latest short interest report for BioXcel Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBTAI Short Interest Over TimeBTAI Days to Cover Over TimeBTAI Percentage of Float Shorted Over Time Ad Porter & CompanyViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberry reveals what happened during his trip to Mar-a-Lago, his meeting with Donald Trump, and the 10 urgent money moves to make before Jan 20 inauguration. Your link to watch Trump’s Secret Stocks is here. BioXcel Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20241,050,000 shares $432,705.00 +16.8%N/A1.7 $0.41 11/30/2024898,700 shares $367,298.69 +44.0%N/A1.4 $0.41 11/15/2024624,100 shares $354,676.03 +79.8%N/A1.2 $0.57 10/31/2024347,100 shares $231,446.28 -39.8%N/A0.7 $0.67 10/15/2024576,400 shares $327,913.96 +11.6%N/A1.2 $0.57 9/30/2024516,400 shares $315,004.00 -26.0%N/A0.9 $0.61 Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024697,600 shares $474,368.00 +2.5%N/A1.1 $0.68 8/31/2024680,500 shares $418,507.50 -6.9%N/A1.2 $0.62 8/15/2024731,200 shares $497,216.00 -9.4%N/A1.2 $0.68 7/31/2024807,300 shares $904,176.00 +28.9%N/A1.2 $1.12 7/15/2024626,100 shares $763,842.00 -61.4%N/A1 $1.22 6/30/20241,620,000 shares $2.07 million +8.7%N/A2.8 $1.28 6/15/20241,490,000 shares $2.04 million +0.7%N/A2.9 $1.37 5/31/20241,480,000 shares $2.68 million -9.2%N/A2.6 $1.81 5/15/20241,630,000 shares $3.36 million +8.7%N/A2.8 $2.06 4/30/20241,500,000 shares $3.78 million -28.2%N/A1 $2.52 4/15/20242,090,000 shares $5.75 million -16.1%N/A1.4 $2.75 3/31/20242,490,000 shares $7.02 million -20.7%10.5%1.7 $2.82 3/15/20243,140,000 shares $8.42 million -20.9%14.6%2.1 $2.68 2/29/20243,970,000 shares $12.62 million -46.8%18.7%2.6 $3.18 2/15/20247,460,000 shares $26.78 million +203.3%35.2%4.9 $3.59 1/31/20242,460,000 shares $7.92 million -17.5%11.9%2.1 $3.22 1/15/20242,980,000 shares $7.84 million +0.3%14.4%1.1 $2.63 12/31/20232,970,000 shares $8.76 million +3.5%14.7%1 $2.95 12/15/20232,870,000 shares $9.30 million -16.6%14.2%0.9 $3.24 11/30/20233,440,000 shares $13.07 million -32.3%17.0%1.1 $3.80 11/15/20235,080,000 shares $22.35 million -12.6%25.1%1.6 $4.40 10/31/20235,810,000 shares $23.33 million +16.9%28.8%1.9 $4.02 10/15/20234,970,000 shares $15.56 million +38.8%24.6%3.6 $3.13 9/30/20233,580,000 shares $9.06 million -24.6%17.7%2.4 $2.53 9/15/20234,750,000 shares $15.87 million +8.0%23.5%1.6 $3.34 8/31/20234,400,000 shares $16.63 million -34.8%21.8%1.5 $3.78 8/15/20236,750,000 shares $27.95 million -4.1%33.5%2.3 $4.14 7/31/20237,040,000 shares $64.35 million -18.8%35.0%2.7 $9.14 7/15/20238,670,000 shares $89.30 million +69.0%43.1%3.5 $10.30 6/30/20235,130,000 shares $34.17 million +12.3%25.5%2.2 $6.66 6/15/20234,570,000 shares $98.26 million +22.9%22.7%8.3 $21.50 5/31/20233,720,000 shares $66.74 million +11.0%18.5%6.2 $17.94 5/15/20233,350,000 shares $91.22 million -5.4%16.7%6.5 $27.23 4/30/20233,540,000 shares $72.99 million -5.1%17.7%6.9 $20.62Viral Trump video released (Ad)Porter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberry reveals what happened during his trip to Mar-a-Lago, his meeting with Donald Trump, and the 10 urgent money moves to make before Jan 20 inauguration. Your link to watch Trump’s Secret Stocks is here. 4/15/20233,730,000 shares $69.90 million +3.6%18.6%7.4 $18.74 3/31/20233,600,000 shares $67.18 million +21.2%18.3%7.2 $18.66 3/15/20232,970,000 shares $58.21 million +5.7%15.1%6.3 $19.60 2/28/20232,810,000 shares $89.70 million +8.9%14.7%8 $31.92 2/15/20232,580,000 shares $84.29 million +5.3%13.5%7.6 $32.67 1/31/20232,450,000 shares $69.87 million +5.6%12.9%7.4 $28.52 1/15/20232,320,000 shares $67.14 million -3.3%12.2%8.1 $28.94 12/30/20222,400,000 shares $51.55 million +10.1%12.6%9.4 $21.48 12/15/20222,180,000 shares $44.04 million -4.4%11.5%9 $20.20 11/30/20222,280,000 shares $37.78 million -3.4%12.0%10.2 $16.57 11/15/20222,360,000 shares $38.00 million -6.7%12.4%10.9 $16.10 10/31/20222,530,000 shares $31.85 million -4.2%13.3%11.7 $12.59 10/15/20222,640,000 shares $27.06 million -5.7%13.9%11.1 $10.25 9/30/20222,800,000 shares $33.10 million -2.1%14.7%10.4 $11.82 9/15/20222,860,000 shares $37.95 million -2.4%15.0%8.5 $13.27 8/31/20222,930,000 shares $40.08 million -0.3%15.4%6.9 $13.68 8/15/20222,940,000 shares $44.86 million +7.7%15.5%6.1 $15.26 7/31/20222,730,000 shares $42.15 million -5.5%14.4%5 $15.44 7/15/20222,890,000 shares $48.70 million -19.7%15.2%5 $16.85 6/30/20223,600,000 shares $47.52 million -9.3%19.0%4 $13.20 6/15/20223,970,000 shares $39.14 million -1.2%20.9%4.4 $9.86 5/31/20224,020,000 shares $47.03 million -2.9%21.2%4.8 $11.70 5/15/20224,140,000 shares $48.60 million +5.3%21.8%5.2 $11.74 4/30/20223,930,000 shares $51.52 million -3.0%20.7%5.3 $13.11 4/15/20224,050,000 shares $63.10 million +97.6%21.4%5.7 $15.58 3/31/20222,050,000 shares $42.87 million +9.0%10.8%3.3 $20.91 3/15/20221,880,000 shares $28.31 million +0.5%9.9%6.1 $15.06 2/28/20221,870,000 shares $34.24 million +10.7%9.9%6.5 $18.31 2/15/20221,690,000 shares $31.38 million -5.1%8.9%5.4 $18.57 1/31/20221,780,000 shares $30.08 million -0.6%9.4%5.5 $16.90 1/15/20221,790,000 shares $34.91 million +3.5%9.4%5.9 $19.50 12/31/20211,730,000 shares $35.17 million -11.7%9.1%5.7 $20.33 12/15/20211,960,000 shares $42.59 million -1.0%10.3%6.7 $21.73 11/30/20211,980,000 shares $45.40 million +10.6%10.4%6.9 $22.93 11/15/20211,790,000 shares $48.71 million -4.3%9.4%6.6 $27.21 10/29/20211,870,000 shares $54.49 million +8.1%9.9%7.5 $29.14 10/15/20211,730,000 shares $46.87 million -6.0%9.1%6.7 $27.09 9/30/20211,840,000 shares $55.84 million -3.2%9.7%6.9 $30.35 9/15/20211,900,000 shares $56.51 million -6.9%10.0%5.4 $29.74 8/31/20212,040,000 shares $60.08 million -8.1%10.8%5.4 $29.45 8/13/20212,220,000 shares $54.59 million -5.9%11.8%5.9 $24.59 7/30/20212,360,000 shares $60.39 million -9.9%12.6%6.1 $25.59 7/15/20212,620,000 shares $70.11 million -11.8%14.0%6.8 $26.76 6/30/20212,970,000 shares $86.31 million +2.1%16.9%7.7 $29.06 6/15/20212,910,000 shares $108.60 million -5.5%19.2%7.8 $37.32 5/28/20213,080,000 shares $101.73 million -3.1%20.3%7.8 $33.03 5/14/20213,180,000 shares $96.67 million -5.6%21.0%7.3 $30.40 4/30/20213,370,000 shares $116.27 million -7.7%22.3%7.1 $34.50 4/15/20213,650,000 shares $127.57 million +9.0%N/A7 $34.95 3/31/20213,350,000 shares $137.69 million -9.7%21.4%6.1 $41.10Viral Trump video released (Ad)Porter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberry reveals what happened during his trip to Mar-a-Lago, his meeting with Donald Trump, and the 10 urgent money moves to make before Jan 20 inauguration. Your link to watch Trump’s Secret Stocks is here. 3/15/20213,710,000 shares $174.33 million +2.8%23.8%6.5 $46.99 2/26/20213,610,000 shares $199.09 million +1.1%23.4%6.7 $55.15 2/12/20213,570,000 shares $230.62 million +5.6%23.1%6.8 $64.60 1/29/20213,380,000 shares $156.33 million -7.9%23.0%6.6 $46.25 1/15/20213,670,000 shares $198.55 million +10.2%25.0%7.7 $54.10 12/31/20203,330,000 shares $163.90 million +4.4%22.7%6.9 $49.22 12/15/20203,190,000 shares $147.89 million -2.5%21.8%7.2 $46.36 11/30/20203,270,000 shares $145.81 million +10.9%22.3%7.2 $44.59 11/15/20202,950,000 shares $160.13 million +4.2%20.1%6.2 $54.28 10/30/20202,830,000 shares $133.15 million +22.0%22.4%5.2 $47.05 10/15/20202,320,000 shares $120.41 million -13.8%18.3%3.5 $51.90 9/30/20202,690,000 shares $116.64 million +17.0%21.3%3.9 $43.36 9/15/20202,300,000 shares $111.09 million +6.5%18.2%3.3 $48.30 8/31/20202,160,000 shares $88.02 million -10.4%17.1%3.1 $40.75 8/14/20202,410,000 shares $90.42 million -14.2%20.7%3.5 $37.52 7/31/20202,810,000 shares $127.46 million +30.1%22.3%4.6 $45.36 7/15/20202,160,000 shares $109.08 million -3.6%20.6%4.3 $50.50 6/30/20202,240,000 shares $118.74 million +137.3%21.3%4.8 $53.01 6/15/2020944,000 shares $44.91 million +39.9%9.0%2.1 $47.57 5/29/2020674,800 shares $31.42 million -13.6%6.4%1.4 $46.56 5/15/2020781,000 shares $36.83 million -8.4%7.4%1.4 $47.16 4/30/2020852,400 shares $31.54 million +30.0%8.1%1.2 $37.00 4/15/2020655,500 shares $15.68 million +8.4%6.3%1 $23.92 3/31/2020604,900 shares $18.67 million -21.2%5.9%0.9 $30.87 3/13/2020767,800 shares $17.83 million +57.6%7.5%1 $23.22 2/28/2020487,300 shares $8.64 million +15.5%4.8%0.9 $17.74 2/14/2020421,800 shares $13.40 million -4.7%4.7%0.9 $31.78 1/31/2020442,500 shares $14.37 million -3.2%5.4%1.7 $32.48 1/15/2020457,000 shares $9.81 million -23.2%5.6%2 $21.46 12/31/2019595,200 shares $10.41 million +2.3%7.3%2.8 $17.49 BTAI Short Interest - Frequently Asked Questions What is BioXcel Therapeutics' current short interest? Short interest is the volume of BioXcel Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 1,050,000 shares of BTAI short. Learn More on BioXcel Therapeutics' current short interest. What is a good short interest ratio for BioXcel Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BTAI shares currently have a short interest ratio of 2.0. Learn More on BioXcel Therapeutics's short interest ratio. Is BioXcel Therapeutics' short interest increasing or decreasing? BioXcel Therapeutics saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 1,050,000 shares, an increase of 16.8% from the previous total of 898,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioXcel Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioXcel Therapeutics: Repare Therapeutics Inc. (2.94%), Mural Oncology plc (2.89%), Galectin Therapeutics Inc. (19.04%), Connect Biopharma Holdings Limited (0.16%), IO Biotech, Inc. (0.32%), Invivyd, Inc. (4.92%), Dyadic International, Inc. (0.76%), Shattuck Labs, Inc. (4.75%), AlloVir, Inc. (1.46%), Celularity Inc. (3.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short BioXcel Therapeutics stock? Short selling BTAI is an investing strategy that aims to generate trading profit from BioXcel Therapeutics as its price is falling. BTAI shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioXcel Therapeutics? A short squeeze for BioXcel Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BTAI, which in turn drives the price of the stock up even further. How often is BioXcel Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTAI, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies RPTX Short Squeeze MURA Short Squeeze GALT Short Squeeze CNTB Short Squeeze IOBT Short Squeeze IVVD Short Squeeze DYAI Short Squeeze STTK Short Squeeze ALVR Short Squeeze CELU Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BTAI) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
